4,4',4''-(Benzene-1,3,5-triyltris(oxy))tribenzonitrile, 97%, 25g

3-(2-Fluoro-4-methoxyphenyl)propanoic acid, 95.0%, 100mg

(S)-6-(5-Bromo-1-((1r,4S)-4-methoxycyclohexyl)-1H-benzo[d]imidazol-2-yl)-1-(3,4-difluorophenyl)piperidin-2-one, 98%, 50mg

(E)-2-(3-Methoxystyryl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 250mg

N-Carbobenzoxy-L-threonine Benzyl Ester>98.0%(HPLC)(N)5g

1H,1'H-2,2'-Biimidazole, 95.0%, 25g

2-Hydrazinobenzoic acid hydrochloride, 97.0%, 25g

3-(4-Aminobutyl)-1H-Indole-5-carbonitrile, 98%, 250mg

4,5-Dibromo-2-fluorotoluene, 95.0%, 5g

5-(Piperidin-1-yl)pentan-1-ol, 98%, 250mg

ethyl 7-(4-hexyloxyphenyl)-7-oxoheptanoate, 97.0%, 2g

7-(Trifluoromethyl)isoquinolin-3-amine, 95+%, 1g

anti-Vimentin mouse monoclonal, VIM 3B4, 0.2 ml